Source link : https://newshealth.biz/health-news/another-b-cell-drug-for-lupus-hits-the-mark/
(MedPage Today) — Obinutuzumab (Gazyva) appears set to add systemic lupus erythematosus (SLE) to its list of approved indications, as results from a phase III trial showed it was significantly more effective than placebo, with no new safety concerns… Source link : https://www.medpagetoday.com/rheumatology/lupus/120193 Author : Publish date : 2026-03-06 16:05:00 Copyright for syndicated content belongs […]
The post Another B-Cell Drug for Lupus Hits the Mark first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-06 16:05:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8